Suzette
Suzette Belder-Carr, Hopewell, NJ US
Patent application number | Description | Published |
---|---|---|
20130230518 | METHODS FOR TREATING SJOGRENS SYNDROME BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE - The present invention relates to compositions and methods for treating autoimmune diseases, such as Sjogren's syndrome, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands. | 09-05-2013 |
20130251713 | METHODS FOR TREATING JUVENILE RHUMATOID ARTHRITIS BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE - The present invention relates to compositions and methods for treating autoimmune diseases, such as juvenile rheumatoid arthritis, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands. | 09-26-2013 |
20140286948 | METHODS FOR TREATING SCLERODERMA BY ADMINISTERING A SOLUBLE CTLA4 MOLECULE - The present invention relates to compositions and methods for treating autoimmune diseases, such as scleroderma, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands. | 09-25-2014 |
Suzette Delaloge, Longjumeau FR
Patent application number | Description | Published |
---|---|---|
20110009286 | MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCER - The invention relates to the use of a multiplicity of polynucleotide probe sets, the multiplicity of polynucleotide probe sets consisting in a combination of pools of polynucleotide probe sets, each polynucleotide probe set containing at least one polynucleotide probe chosen among a library of nucleic acid sequences, the polynucleotide probes involved in the combination of pools of polynucleotide probe sets of the multiplicity of polynucleotide probe sets being such that each polynucleotide probe specifically hybridizes with one gene, and/or at least one of its variants when present, for determining the variation of expression at least 12 genes, and their variants when present, in order to diagnose the benign or malignant state of a breast tumor. | 01-13-2011 |
20120283132 | MOLECULAR IN VITRO DIAGNOSIS OF BREAST CANCER - A method for determining the benign or malignant state of a breast tumor in a biological sample is presented. The benign or malignant state is determined by measuring the variation of expression of twelve genes and at least one variant of each of the twelve genes when the variants exist, using a combination of 50 polynucleotide probe sets. An expression profile of the sample is then compared with reference expression profiles of control benign and malignant breast tissues. The probe sets can be arranged in a microarray. | 11-08-2012 |
Suzette Farber-Katz, Rancho Santa Margarita, CA US
Patent application number | Description | Published |
---|---|---|
20100286220 | HNF4alpha ANTAGONISTS AND METHODS OF USE - Disclosed are methods and compositions relating to antagonists of HNF4α. | 11-11-2010 |
Suzette Oxendine, Virginia Beach, VA US
Patent application number | Description | Published |
---|---|---|
20120109701 | Fulfillment Workflow Optimization - A system and method for an optimization of fulfillment workflow is disclosed. In accordance with one embodiment of the present disclosure. In accordance with embodiments of the present disclosure, a method may include receiving a request to be fulfilled from a client. The method may also include determining one or more item attributes associated with the request. The method may additionally include generating a batch of work units related to the request based at least in part on the one or more item attributes. The method may further include selecting an agent from a plurality of agents to process the batch. Moreover, the method may include transmitting the batch to the agent. | 05-03-2012 |